Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 339896
Gene Symbol: GADL1
GADL1
0.320 GeneticVariation disease BEFREE These findings suggest that rs17026688 polymorphisms in GADL1 are associated with immune dysfunction in BDI patients. 31767892 2019
Entrez Id: 339896
Gene Symbol: GADL1
GADL1
0.320 GeneticVariation disease BEFREE Genetic variations in GADL1 are associated with the response to lithium maintenance treatment for bipolar I disorder in patients of Han Chinese descent.(Funded by Academia Sinica and others.). 24369049 2014
Entrez Id: 339896
Gene Symbol: GADL1
GADL1
0.320 Biomarker disease PSYGENET Genetic variations in GADL1 are associated with the response to lithium maintenance treatment for bipolar I disorder in patients of Han Chinese descent.(Funded by Academia Sinica and others.). 24369049 2014
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.320 Biomarker disease PSYGENET Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. 23072837 2013
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.320 GeneticVariation disease BEFREE Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. 23072837 2013
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.320 AlteredExpression disease BEFREE Bcl-2 mRNA and protein levels were lowest in BD-I G/G patients. 21320251 2011
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.320 Biomarker disease PSYGENET Bcl-2 mRNA and protein levels were lowest in BD-I G/G patients. 21320251 2011
Entrez Id: 9369
Gene Symbol: NRXN3
NRXN3
0.310 GeneticVariation disease BEFREE For markers genotyped in replication samples, rs7619173 exhibited a significant association (P(combined) = 2 ∗ 10(-4)) after multiple testing correction, while markers rs11001178 (MYST4) and rs2217887 (NRXN3) showed weak associations (P(combined) = 0.02) with BPD-I. 24444492 2014
Entrez Id: 23522
Gene Symbol: KAT6B
KAT6B
0.310 GeneticVariation disease BEFREE For markers genotyped in replication samples, rs7619173 exhibited a significant association (P(combined) = 2 ∗ 10(-4)) after multiple testing correction, while markers rs11001178 (MYST4) and rs2217887 (NRXN3) showed weak associations (P(combined) = 0.02) with BPD-I. 24444492 2014
Entrez Id: 9369
Gene Symbol: NRXN3
NRXN3
0.310 Biomarker disease PSYGENET For markers genotyped in replication samples, rs7619173 exhibited a significant association (P(combined) = 2 ∗ 10(-4)) after multiple testing correction, while markers rs11001178 (MYST4) and rs2217887 (NRXN3) showed weak associations (P(combined) = 0.02) with BPD-I. 24444492 2014
Entrez Id: 23522
Gene Symbol: KAT6B
KAT6B
0.310 Biomarker disease PSYGENET For markers genotyped in replication samples, rs7619173 exhibited a significant association (P(combined) = 2 ∗ 10(-4)) after multiple testing correction, while markers rs11001178 (MYST4) and rs2217887 (NRXN3) showed weak associations (P(combined) = 0.02) with BPD-I. 24444492 2014
Entrez Id: 5444
Gene Symbol: PON1
PON1
0.310 GeneticVariation disease BEFREE Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene. 21783258 2012
Entrez Id: 5444
Gene Symbol: PON1
PON1
0.310 Biomarker disease PSYGENET Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene. 21783258 2012
Entrez Id: 1958
Gene Symbol: EGR1
EGR1
0.310 Biomarker disease BEFREE None of the SNPs tested in EGR1, EGR2, or EGR4 was associated with child BP-I. 22370066 2012
Entrez Id: 1961
Gene Symbol: EGR4
EGR4
0.310 Biomarker disease BEFREE None of the SNPs tested in EGR1, EGR2, or EGR4 was associated with child BP-I. 22370066 2012
Entrez Id: 85413
Gene Symbol: SLC22A16
SLC22A16
0.310 Biomarker disease PSYGENET Although consistent evidence of association with any single variant was not seen across samples, SNP-wise and gene-based test results in the three samples provided convergent evidence for association with SLC22A16, a carnitine transporter, implicating this gene as a novel candidate for BPI risk. 19308960 2010
Entrez Id: 85413
Gene Symbol: SLC22A16
SLC22A16
0.310 Biomarker disease BEFREE Although consistent evidence of association with any single variant was not seen across samples, SNP-wise and gene-based test results in the three samples provided convergent evidence for association with SLC22A16, a carnitine transporter, implicating this gene as a novel candidate for BPI risk. 19308960 2010
Entrez Id: 10718
Gene Symbol: NRG3
NRG3
0.310 AlteredExpression disease BEFREE These data suggest any change in NRG1Ialpha and NRG3 expression in schizophrenia or bipolar 1 disorder do not result in changes levels in levels of those proteins Brodmann's area 46. 19765633 2009
Entrez Id: 7494
Gene Symbol: XBP1
XBP1
0.310 Biomarker disease PSYGENET Moreover, an effect of XBP1 -116C/G polymorphism could not account for the attenuated XBP1 induction in bipolar-I disorder observed in this study. 17217928 2007
Entrez Id: 7494
Gene Symbol: XBP1
XBP1
0.310 GeneticVariation disease BEFREE Moreover, an effect of XBP1 -116C/G polymorphism could not account for the attenuated XBP1 induction in bipolar-I disorder observed in this study. 17217928 2007
Entrez Id: 3309
Gene Symbol: HSPA5
HSPA5
0.310 AlteredExpression disease BEFREE Endoplasmic reticulum stress-induced X-box binding protein 1 (XBP1), C/EBP homologous protein (CHOP), and GRP78 expression in BLCLs from BD-I subjects stratified on elevated or normal [Ca2+]B and control subjects were determined by real-time quantitative reverse transcription polymerase chain reaction. 17217928 2007
Entrez Id: 2899
Gene Symbol: GRIK3
GRIK3
0.310 GeneticVariation disease BEFREE We detected a significant linkage disequilibrium (LD) indicated by preferential maternal transmission of the GluR7 S310 allele to R-MDD patients (P = 0.012), but not to bipolar I disorder (BPI) patients (P = 1.00). 16958029 2007
Entrez Id: 1610
Gene Symbol: DAO
DAO
0.310 AlteredExpression disease BEFREE Six genes (DAO, GRM3, GRM4, GRIN2B, IL2RB, and TUBA8) met this criterion for bipolar I disorder; only DAO has been previously associated with bipolar disorder. 16380905 2005
Entrez Id: 1610
Gene Symbol: DAO
DAO
0.310 Biomarker disease PSYGENET Six genes (DAO, GRM3, GRM4, GRIN2B, IL2RB, and TUBA8) met this criterion for bipolar I disorder; only DAO has been previously associated with bipolar disorder. 16380905 2005
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.310 GeneticVariation disease BEFREE The present study suggests that the MCP1 promoter -2518 polymorphism may not confer susceptibility to BID itself, but could have an influence on the clinical heterogeneity of BID, at least in the Korean population. 15034225 2004